Header Logo

Connection

Joan Lo to Middle Aged

Back to Details
This is a "connection" page, showing publications Joan Lo has written about Middle Aged.
Joan Lo
Connection Strength
2.458
Middle Aged
  1. Description of Major Osteoporotic Fractures in Women with Invasive Breast Cancer Who Received Endocrine Therapy. JAMA Netw Open. 2021 11 01; 4(11):e2133861.
    View in: PubMed
    Score: 0.086
  2. Risk of complete atypical femur fracture with Oral bisphosphonate exposure beyond three years. BMC Musculoskelet Disord. 2020 Dec 03; 21(1):801.
    View in: PubMed
    Score: 0.080
  3. Bone Mineral Density in Older U.S. Filipino, Chinese, Japanese, and White Women. J Am Geriatr Soc. 2020 11; 68(11):2656-2661.
    View in: PubMed
    Score: 0.080
  4. The Epidemiology of Metatarsal Fractures Among Older Females With Bisphosphonate Exposure. J Foot Ankle Surg. 2020 Mar - Apr; 59(2):269-273.
    View in: PubMed
    Score: 0.076
  5. Aggregation of Asian-American subgroups masks meaningful differences in health and health risks among Asian ethnicities: an electronic health record based cohort study. BMC Public Health. 2019 Nov 25; 19(1):1551.
    View in: PubMed
    Score: 0.075
  6. Atypical femur fracture incidence in women increases with duration of bisphosphonate exposure. Osteoporos Int. 2019 Dec; 30(12):2515-2520.
    View in: PubMed
    Score: 0.074
  7. Depot Medroxyprogesterone Acetate, Oral Contraceptive, Intrauterine Device Use, and Fracture Risk. Obstet Gynecol. 2019 09; 134(3):581-589.
    View in: PubMed
    Score: 0.074
  8. Vitamin D Status Among Older Women Initiating Osteoporosis Therapy. J Am Geriatr Soc. 2019 10; 67(10):2207-2208.
    View in: PubMed
    Score: 0.073
  9. Changes in bone mineral density in women with breast cancer receiving aromatase inhibitor therapy. Breast Cancer Res Treat. 2018 Apr; 168(2):523-530.
    View in: PubMed
    Score: 0.065
  10. Contemporary rates and correlates of statin use and adherence in nondiabetic adults with cardiovascular risk factors: The KP CHAMP study. Am Heart J. 2017 Dec; 194:25-38.
    View in: PubMed
    Score: 0.064
  11. Thyroid function in end stage renal disease and effects of frequent hemodialysis. Hemodial Int. 2017 10; 21(4):534-541.
    View in: PubMed
    Score: 0.062
  12. Changing Patterns in Oral Bisphosphonate Initiation in Women between 2004 and 2012. J Am Geriatr Soc. 2017 03; 65(3):656-658.
    View in: PubMed
    Score: 0.062
  13. Hyperprolactinemia in end-stage renal disease and effects of frequent hemodialysis. Hemodial Int. 2017 04; 21(2):190-196.
    View in: PubMed
    Score: 0.060
  14. Applying ethnic-specific bone mineral density T-scores to Chinese women in the USA. Osteoporos Int. 2016 12; 27(12):3477-3484.
    View in: PubMed
    Score: 0.059
  15. The association of race/ethnicity and risk of atypical femur fracture among older women receiving oral bisphosphonate therapy. Bone. 2016 Apr; 85:142-7.
    View in: PubMed
    Score: 0.057
  16. Racial/ethnic differences in hip and diaphyseal femur fractures. Osteoporos Int. 2014 Sep; 25(9):2313-8.
    View in: PubMed
    Score: 0.051
  17. Clinical characteristics, bone mineral density and non-vertebral osteoporotic fracture outcomes among post-menopausal U.S. South Asian Women. Bone. 2012 Dec; 51(6):1025-8.
    View in: PubMed
    Score: 0.045
  18. Atypical femur fractures among breast cancer and multiple myeloma patients receiving intravenous bisphosphonate therapy. Bone. 2012 Sep; 51(3):524-7.
    View in: PubMed
    Score: 0.044
  19. Bisphosphonate-related osteonecrosis of the jaw in patients with oral bisphosphonate exposure: clinical course and outcomes. J Oral Maxillofac Surg. 2012 Aug; 70(8):1844-53.
    View in: PubMed
    Score: 0.044
  20. Clinical correlates of atypical femoral fracture. Bone. 2012 Jul; 51(1):181-4.
    View in: PubMed
    Score: 0.044
  21. The impact of subtrochanteric fracture criteria on hip fracture classification. Osteoporos Int. 2012 Feb; 23(2):743-50.
    View in: PubMed
    Score: 0.041
  22. Oral health considerations in older women receiving oral bisphosphonate therapy. J Am Geriatr Soc. 2011 May; 59(5):916-22.
    View in: PubMed
    Score: 0.041
  23. Fracture risk tool validation in an integrated healthcare delivery system. Am J Manag Care. 2011 Mar; 17(3):188-94.
    View in: PubMed
    Score: 0.041
  24. Radiographic findings in bisphosphonate-treated patients with stage 0 disease in the absence of bone exposure. J Oral Maxillofac Surg. 2010 Sep; 68(9):2232-40.
    View in: PubMed
    Score: 0.039
  25. Intravenous bisphosphonate-related osteonecrosis of the jaw: bone scintigraphy as an early indicator. J Oral Maxillofac Surg. 2009 Jul; 67(7):1363-72.
    View in: PubMed
    Score: 0.036
  26. GFR, body mass index, and low high-density lipoprotein concentration in adults with and without CKD. Am J Kidney Dis. 2007 Oct; 50(4):552-8.
    View in: PubMed
    Score: 0.032
  27. The association of genetic polymorphisms in sex hormone biosynthesis and action with insulin sensitivity and diabetes mellitus in women at midlife. Am J Med. 2006 Sep; 119(9 Suppl 1):S69-78.
    View in: PubMed
    Score: 0.030
  28. Persistence with weekly alendronate therapy among postmenopausal women. Osteoporos Int. 2006; 17(6):922-8.
    View in: PubMed
    Score: 0.029
  29. Effectiveness of bisphosphonate use and risk of contralateral breast cancer and recurrence in women with early-stage breast cancer treated with tamoxifen. Breast Cancer Res Treat. 2016 Apr; 156(2):379-89.
    View in: PubMed
    Score: 0.029
  30. Association of high obesity with PAM50 breast cancer intrinsic subtypes and gene expression. BMC Cancer. 2015 Apr 14; 15:278.
    View in: PubMed
    Score: 0.027
  31. Increased prevalence of subclinical and clinical hypothyroidism in persons with chronic kidney disease. Kidney Int. 2005 Mar; 67(3):1047-52.
    View in: PubMed
    Score: 0.027
  32. Rationale and design of the KP ENRICH trial: A food is medicine intervention in low-income high-risk adults with diabetes within Kaiser Permanente. Contemp Clin Trials. 2024 Aug; 143:107601.
    View in: PubMed
    Score: 0.026
  33. Fracture Risk and Association With TDF Use Among People With HIV in Large Integrated Health Systems. J Acquir Immune Defic Syndr. 2023 12 01; 94(4):341-348.
    View in: PubMed
    Score: 0.025
  34. Postdiagnosis alcohol consumption and breast cancer prognosis in the after breast cancer pooling project. Cancer Epidemiol Biomarkers Prev. 2013 Jan; 22(1):32-41.
    View in: PubMed
    Score: 0.023
  35. Prevalence of prediabetes and diabetes vary by ethnicity among U.S. Asian adults at healthy weight, overweight, and obesity ranges: an electronic health record study. BMC Public Health. 2022 10 22; 22(1):1954.
    View in: PubMed
    Score: 0.023
  36. Patient awareness and knowledge of breast cancer-related lymphedema in a large, integrated health care delivery system. Breast Cancer Res Treat. 2012 Sep; 135(2):591-602.
    View in: PubMed
    Score: 0.023
  37. Change in physical activity during active treatment in a prospective study of breast cancer survivors. Breast Cancer Res Treat. 2012 Jan; 131(2):679-90.
    View in: PubMed
    Score: 0.021
  38. Bisphosphonate Treatment Beyond 5 Years and Hip Fracture Risk in Older Women. JAMA Netw Open. 2020 12 01; 3(12):e2025190.
    View in: PubMed
    Score: 0.020
  39. Risk factors for lymphedema in a prospective breast cancer survivorship study: the Pathways Study. Arch Surg. 2010 Nov; 145(11):1055-63.
    View in: PubMed
    Score: 0.020
  40. A practical method for collecting food record data in a prospective cohort study of breast cancer survivors. Am J Epidemiol. 2010 Dec 01; 172(11):1315-23.
    View in: PubMed
    Score: 0.020
  41. Alcohol consumption and breast cancer recurrence and survival among women with early-stage breast cancer: the life after cancer epidemiology study. J Clin Oncol. 2010 Oct 10; 28(29):4410-6.
    View in: PubMed
    Score: 0.020
  42. Cardiac valvular abnormalities associated with use and cumulative exposure of cabergoline for hyperprolactinemia: the CATCH study. BMC Endocr Disord. 2020 Feb 19; 20(1):25.
    View in: PubMed
    Score: 0.019
  43. Quality of life among women recently diagnosed with invasive breast cancer: the Pathways Study. Breast Cancer Res Treat. 2010 Sep; 123(2):507-24.
    View in: PubMed
    Score: 0.019
  44. Determinants of Oral Bisphosphonate Use Beyond 5 Years. J Manag Care Spec Pharm. 2020 Feb; 26(2):197-202.
    View in: PubMed
    Score: 0.019
  45. Identifying Key Risk Factors for Dizziness Handicap in Middle-Aged and Older People. J Am Med Dir Assoc. 2020 03; 21(3):344-350.e2.
    View in: PubMed
    Score: 0.019
  46. The Be-Well Study: a prospective cohort study of lifestyle and genetic factors to reduce the risk of recurrence and progression of non-muscle-invasive bladder cancer. Cancer Causes Control. 2019 Feb; 30(2):187-193.
    View in: PubMed
    Score: 0.018
  47. Dietary patterns and breast cancer recurrence and survival among women with early-stage breast cancer. J Clin Oncol. 2009 Feb 20; 27(6):919-26.
    View in: PubMed
    Score: 0.018
  48. Reducing the burden of dizziness in middle-aged and older people: A multifactorial, tailored, single-blind randomized controlled trial. PLoS Med. 2018 07; 15(7):e1002620.
    View in: PubMed
    Score: 0.017
  49. Post-diagnosis statin use and breast cancer recurrence in a prospective cohort study of early stage breast cancer survivors. Breast Cancer Res Treat. 2008 Jun; 109(3):573-9.
    View in: PubMed
    Score: 0.016
  50. NSAIDs and breast cancer recurrence in a prospective cohort study. Cancer Causes Control. 2007 Aug; 18(6):613-20.
    View in: PubMed
    Score: 0.016
  51. Patterns and reasons for switching classes of hormonal therapy among women with early-stage breast cancer. Cancer Causes Control. 2017 Jun; 28(6):557-562.
    View in: PubMed
    Score: 0.016
  52. Tailored multifactorial intervention to improve dizziness symptoms and quality of life, balance and gait in dizziness sufferers aged over 50 years: protocol for a randomised controlled trial. BMC Geriatr. 2017 02 15; 17(1):56.
    View in: PubMed
    Score: 0.015
  53. Urinary N-telopeptide and Rate of Bone Loss Over the Menopause Transition and Early Postmenopause. J Bone Miner Res. 2016 11; 31(11):2057-2064.
    View in: PubMed
    Score: 0.015
  54. Race/ethnicity, genetic ancestry, and breast cancer-related lymphedema in the Pathways Study. Breast Cancer Res Treat. 2016 08; 159(1):119-29.
    View in: PubMed
    Score: 0.015
  55. Accuracy of the Atherosclerotic Cardiovascular Risk Equation in a Large Contemporary, Multiethnic Population. J Am Coll Cardiol. 2016 05 10; 67(18):2118-2130.
    View in: PubMed
    Score: 0.015
  56. Retinopathy and the risk of cardiovascular disease in patients with chronic kidney disease (from the Chronic Renal Insufficiency Cohort study). Am J Cardiol. 2015 Nov 15; 116(10):1527-33.
    View in: PubMed
    Score: 0.014
  57. Breastfeeding, PAM50 tumor subtype, and breast cancer prognosis and survival. J Natl Cancer Inst. 2015 Jul; 107(7).
    View in: PubMed
    Score: 0.014
  58. Serum 25 hydroxyvitamin D, bone mineral density and fracture risk across the menopause. J Clin Endocrinol Metab. 2015 May; 100(5):2046-54.
    View in: PubMed
    Score: 0.013
  59. Bone health history in breast cancer patients on aromatase inhibitors. PLoS One. 2014; 9(10):e111477.
    View in: PubMed
    Score: 0.013
  60. Retinopathy and progression of CKD: The CRIC study. Clin J Am Soc Nephrol. 2014 Jul; 9(7):1217-24.
    View in: PubMed
    Score: 0.013
  61. Lactation intensity and fasting plasma lipids, lipoproteins, non-esterified free fatty acids, leptin and adiponectin in postpartum women with recent gestational diabetes mellitus: the SWIFT cohort. Metabolism. 2014 Jul; 63(7):941-50.
    View in: PubMed
    Score: 0.013
  62. Increasing use of vitamin D supplementation in the chronic renal insufficiency cohort study. J Ren Nutr. 2014 May; 24(3):186-93.
    View in: PubMed
    Score: 0.013
  63. Physical performance and frailty in chronic kidney disease. Am J Nephrol. 2013; 38(4):307-15.
    View in: PubMed
    Score: 0.012
  64. FGF23 modifies the relationship between vitamin D and cardiac remodeling. Circ Heart Fail. 2013 Jul; 6(4):817-24.
    View in: PubMed
    Score: 0.012
  65. Patient-physician interaction and quality of life in recently diagnosed breast cancer patients. Breast Cancer Res Treat. 2013 Jun; 139(2):581-95.
    View in: PubMed
    Score: 0.012
  66. Ethnic variability in bone geometry as assessed by hip structure analysis: findings from the hip strength across the menopausal transition study. J Bone Miner Res. 2013 Apr; 28(4):771-9.
    View in: PubMed
    Score: 0.012
  67. Bone resorption and fracture across the menopausal transition: the Study of Women's Health Across the Nation. Menopause. 2012 Nov; 19(11):1200-7.
    View in: PubMed
    Score: 0.011
  68. Application of new method for evaluating performance of fracture risk tool. Am J Manag Care. 2012 Oct 01; 18(10):e398.
    View in: PubMed
    Score: 0.011
  69. Retinopathy and chronic kidney disease in the Chronic Renal Insufficiency Cohort (CRIC) study. Arch Ophthalmol. 2012 Sep; 130(9):1136-44.
    View in: PubMed
    Score: 0.011
  70. Treatment of vitamin D deficiency within a large integrated health care delivery system. J Manag Care Pharm. 2012 Sep; 18(7):497-505.
    View in: PubMed
    Score: 0.011
  71. Influence of breastfeeding during the postpartum oral glucose tolerance test on plasma glucose and insulin. Obstet Gynecol. 2012 Jul; 120(1):136-43.
    View in: PubMed
    Score: 0.011
  72. Association between retinopathy and cardiovascular disease in patients with chronic kidney disease (from the Chronic Renal Insufficiency Cohort [CRIC] Study). Am J Cardiol. 2012 Jul 15; 110(2):246-53.
    View in: PubMed
    Score: 0.011
  73. Study of Women, Infant Feeding, and Type 2 diabetes mellitus after GDM pregnancy (SWIFT), a prospective cohort study: methodology and design. BMC Public Health. 2011 Dec 23; 11:952.
    View in: PubMed
    Score: 0.011
  74. Pre-diagnosis body mass index and survival after breast cancer in the After Breast Cancer Pooling Project. Breast Cancer Res Treat. 2012 Apr; 132(2):729-39.
    View in: PubMed
    Score: 0.011
  75. Lactation intensity and postpartum maternal glucose tolerance and insulin resistance in women with recent GDM: the SWIFT cohort. Diabetes Care. 2012 Jan; 35(1):50-6.
    View in: PubMed
    Score: 0.011
  76. Methods for assessing fracture risk prediction models: experience with FRAX in a large integrated health care delivery system. J Clin Densitom. 2011 Oct-Dec; 14(4):407-15.
    View in: PubMed
    Score: 0.011
  77. Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease. JAMA. 2011 Jun 15; 305(23):2432-9.
    View in: PubMed
    Score: 0.010
  78. Multivitamin use and breast cancer outcomes in women with early-stage breast cancer: the Life After Cancer Epidemiology study. Breast Cancer Res Treat. 2011 Nov; 130(1):195-205.
    View in: PubMed
    Score: 0.010
  79. Association of vitamin D insufficiency with carotid intima-media thickness in HIV-infected persons. Clin Infect Dis. 2011 Apr 01; 52(7):941-4.
    View in: PubMed
    Score: 0.010
  80. Prevalence of ocular fundus pathology in patients with chronic kidney disease. Clin J Am Soc Nephrol. 2010 May; 5(5):867-73.
    View in: PubMed
    Score: 0.010
  81. Epidemiology of breast cancer subtypes in two prospective cohort studies of breast cancer survivors. Breast Cancer Res. 2009; 11(3):R31.
    View in: PubMed
    Score: 0.009
  82. Association of adolescent obesity and lifetime nulliparity--the Study of Women's Health Across the Nation (SWAN). Fertil Steril. 2010 Apr; 93(6):2004-11.
    View in: PubMed
    Score: 0.009
  83. Bone mineral density changes during the menopause transition in a multiethnic cohort of women. J Clin Endocrinol Metab. 2008 Mar; 93(3):861-8.
    View in: PubMed
    Score: 0.008
  84. Plasma leptin levels and coronary artery calcification in older adults. J Clin Endocrinol Metab. 2007 Feb; 92(2):729-32.
    View in: PubMed
    Score: 0.008
  85. Statin therapy and risks for death and hospitalization in chronic heart failure. JAMA. 2006 Nov 01; 296(17):2105-11.
    View in: PubMed
    Score: 0.008
  86. Value of the sagittal abdominal diameter in coronary heart disease risk assessment: cohort study in a large, multiethnic population. Am J Epidemiol. 2006 Dec 15; 164(12):1150-9.
    View in: PubMed
    Score: 0.008
  87. Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults. J Am Soc Nephrol. 2005 Jul; 16(7):2134-40.
    View in: PubMed
    Score: 0.007
  88. The Chronic Renal Insufficiency Cohort (CRIC) Study: Design and Methods. J Am Soc Nephrol. 2003 Jul; 14(7 Suppl 2):S148-53.
    View in: PubMed
    Score: 0.006

© 2024 Kaiser Permanente